Target Name: CD34
NCBI ID: G947
Review Report on CD34 Target / Biomarker Content of Review Report on CD34 Target / Biomarker
CD34
Other Name(s): CD34 molecule | CD34 molecule, transcript variant 2 | CD34 variant 1 | Hematopoietic progenitor cell antigen CD34 (isoform b) | CD34 antigen | CD34 variant 2 | Hematopoietic progenitor cell antigen CD34 (isoform a) | CD34 molecule, transcript variant 1 | CD34_HUMAN | Hematopoietic progenitor cell antigen CD34

CD34: A Potential Drug Target and Biomarker

CD34 is a molecule that has gained significant attention in recent years due to its potential as a drug target or biomarker. CD34 is a type of hematopoietic stem cell (HSC) that plays a crucial role in the development and maintenance of tissues in the human body. It is a protein that is expressed in a wide range of tissues, including bone marrow, fat tissue, and the immune system.

CD34 has been shown to be involved in a number of different biological processes in the body, including immune response, tissue repair, and plasticity. It is also has been linked to a number of diseases, including cancer, obesity, and neurodegenerative diseases.

One of the key reasons for the interest in CD34 is its potential as a drug target. CD34 is an ideal candidate for drug treatment because it is a protein that is expressed in a wide range of tissues, making it difficult to target specific and effective drugs. Additionally, its role in a number of different biological processes makes it a promising target for drugs that can modulate its activity.

Another potential use of CD34 is as a biomarker. CD34 has been shown to be a useful marker for tracking the progress of cancer treatments, as well as for monitoring the effectiveness of certain drugs. This is because CD34 is often expressed in higher levels in tissues that are responding to treatment, making it a reliable indicator of the effectiveness of a drug.

CD34 has also been shown to be involved in a number of different signaling pathways in the body. For example, it is a target of the protein PDGF-BB, which is involved in cell proliferation and survival. Additionally, CD34 has been shown to be involved in the TGF-β pathway, which is involved in cell signaling and growth.

In conclusion, CD34 is a molecule that has significant potential as a drug target or biomarker. Its role in the development and maintenance of tissues, as well as its involvement in a number of different signaling pathways, makes it an attractive candidate for drug development. Further research is needed to fully understand the potential of CD34 as a drug and to determine its utility as a biomarker.

Protein Name: CD34 Molecule

Functions: Possible adhesion molecule with a role in early hematopoiesis by mediating the attachment of stem cells to the bone marrow extracellular matrix or directly to stromal cells. Could act as a scaffold for the attachment of lineage specific glycans, allowing stem cells to bind to lectins expressed by stromal cells or other marrow components. Presents carbohydrate ligands to selectins

The "CD34 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CD34 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

CD36 | CD37 | CD38 | CD3D | CD3E | CD3G | CD4 | CD40 | CD40LG | CD44 | CD44-DT | CD46 | CD47 | CD48 | CD5 | CD52 | CD53 | CD55 | CD58 | CD59 | CD5L | CD6 | CD63 | CD68 | CD69 | CD7 | CD70 | CD72 | CD74 | CD79A | CD79B | CD8 | CD80 | CD81 | CD81-AS1 | CD82 | CD83 | CD84 | CD86 | CD8A | CD8B | CD8B2 | CD9 | CD93 | CD96 | CD99 | CD99L2 | CD99P1 | CDA | CDADC1 | CDAN1 | CDC123 | CDC14A | CDC14B | CDC14C | CDC16 | CDC20 | CDC20-DT | CDC20B | CDC20P1 | CDC23 | CDC25A | CDC25B | CDC25C | CDC26 | CDC27 | CDC27P2 | CDC34 | CDC37 | CDC37L1 | CDC37P1 | CDC40 | CDC42 | CDC42BPA | CDC42BPB | CDC42BPG | CDC42EP1 | CDC42EP2 | CDC42EP3 | CDC42EP4 | CDC42EP5 | CDC42SE1 | CDC42SE2 | CDC45 | CDC5L | CDC5L complex | CDC6 | CDC7 | CDC73 | CDCA2 | CDCA3 | CDCA4 | CDCA4P3 | CDCA5 | CDCA7 | CDCA7L | CDCA8 | CDCP1 | CDCP2 | CDH1